Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -321.28% is 81% below its 3-year average of -177.89%, near the low end of its 3-year range (-321.28%–-54.38%).
As of the fiscal period ended Tuesday, June 30, 2026. 35.28% below its 12-month average of -237.49%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -321.28%.
RETURN ON INVESTED CAPITAL (ROIC)
-321.28%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-237.49%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-187.39%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-35.28%
CURRENT VS 3Y AVG
-71.45%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.66%
median of 837 covered companies
CURRENT VS SECTOR MEDIAN
-800.94%
vs the sector median at left
60 Degrees Pharmaceuticals, Inc.
Market Cap
$3.90M
Return on Invested Capital (ROIC)
-321.28%
TTM Avg
-237.49%
3Y Avg
-187.39%
5Y Avg
N/A
Market Cap
$3.93M
Return on Invested Capital (ROIC)
-288.14%
TTM Avg
-190.86%
3Y Avg
-162.44%
5Y Avg
-129.35%
Market Cap
$4.15M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-199.78%
3Y Avg
-1598.70%
5Y Avg
-1598.70%
Market Cap
$3.65M
Return on Invested Capital (ROIC)
-130.12%
TTM Avg
-72.08%
3Y Avg
-61.96%
5Y Avg
-55.38%
Market Cap
$3.65M
Return on Invested Capital (ROIC)
-346.94%
TTM Avg
-467.60%
3Y Avg
-296.93%
5Y Avg
-277.74%
Market Cap
$3.63M
Return on Invested Capital (ROIC)
-9.04%
TTM Avg
-9.04%
3Y Avg
-6.72%
5Y Avg
4.87%
Market Cap
$4.21M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-480.55%
3Y Avg
-363.38%
5Y Avg
-260.65%
Market Cap
$3.53M
Return on Invested Capital (ROIC)
-284.81%
TTM Avg
-319.42%
3Y Avg
-246.02%
5Y Avg
-246.02%
Market Cap
$3.50M
Return on Invested Capital (ROIC)
-33.50%
TTM Avg
-18.16%
3Y Avg
-45.78%
5Y Avg
-36.63%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| 60 Degrees Pharmaceuticals, Inc. (SXTP) | $3.90M | -321.28% | -237.49% | -187.39% | N/A |
| Aptevo Therapeutics Inc. (APVO)vs › | $3.93M | -288.14% | -190.86% | -162.44% | -129.35% |
| GRI Bio, Inc. (GRI)vs › | $4.15M | N/A | -199.78% | -1598.70% | -1598.70% |
| Evogene Ltd. (EVGN)vs › | $3.65M | -130.12% | -72.08% | -61.96% | -55.38% |
| Ernexa Therapeutics Inc. (ERNA)vs › | $3.65M | -346.94% | -467.60% | -296.93% | -277.74% |
| WORK Medical Technology Group Ltd. Class A (WOK)vs › | $3.63M | -9.04% | -9.04% | -6.72% | 4.87% |
| Processa Pharmaceuticals, Inc. (PCSA)vs › | $4.21M | N/A | -480.55% | -363.38% | -260.65% |
| Cadrenal Therapeutics, Inc. Common Stock (CVKD)vs › | $3.53M | -284.81% | -319.42% | -246.02% | -246.02% |
| Moolec Science S.A. (MLEC)vs › | $3.50M | -33.50% | -18.16% | -45.78% | -36.63% |
| Eocene Ltd. (EOCN)vs › | $3.50M | N/A | N/A | N/A | N/A |
ROIC
-321.3%
ROE
-310.3%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -321.28% |
| 2026-03-31 | -162.21% |
| 2025-12-31 | -219.65% |
| 2025-09-30 | -175.91% |
| 2025-06-30 | -308.41% |
| 2025-03-31 | -246.03% |
| 2024-12-31 | -236.58% |
| 2024-09-30 | -155.96% |
| 2024-06-30 | -287.06% |
| 2024-03-31 | -76.15% |
| 2023-12-31 | -103.98% |
| 2023-09-30 | -59.08% |
| 2023-06-30 | -83.77% |
| 2023-03-31 | -54.38% |
